Could a Two-Drug pain block ease recovery after colon cancer surgery?
NCT ID NCT06370949
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial compares two approaches to a nerve block (TAP block) for pain after colorectal cancer surgery. One group receives the standard numbing drug bupivacaine, while the other gets bupivacaine plus dexmedetomidine, a drug that may extend pain relief. The study measures pain scores using a 0–10 scale in the hours after surgery. About 84 adults with colorectal cancer scheduled for surgery are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine and dexmedetomidine
What this could lead to
If it works, this could offer better pain relief after colorectal cancer surgery, reducing the need for strong painkillers.
What could go wrong
This is a small, early-stage trial. The added drug may not improve pain control and could cause side effects like low blood pressure or drowsiness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- CG-100 Bypass Device for Colorectal Cancer (NCT05632744)
- AMPLIFI: Web-Based Lifestyle Program for Cancer NCT04000880
- LIVELONG Trial: Ablative Therapy for GI Cancers NCT06101277
- Preventing Early-Onset Colorectal Cancer in Vete NCT07071454
- Colonoscopy in Breast Cancer Survivors: NCT07678099
- mFOLFOX6+Bevacizumab+PD-1 for MSS Colorectal Can NCT04895137
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Turkey Dr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hospital
Ankara, Cankaya, 06110, Turkey (Türkiye)